Innuana is focused on researching, growing, processing and producing medicinal-grade cannabis.
The legislative shifts will enable Creso Pharma to expand its Swiss operations and enter into the Swiss medicinal cannabis market.
The initial term of the agreement is one year, with an automatic renewal for another year unless either party notifies of a decision to withdraw 30 days before the expiry of the initial or renewal term.